Decode.
We mine massive multi-dimensional datasets to identify targetable nuances in the genetic
code unique to different cell types. Brain vs lung. Malignant vs non-maglinant. Epithelial vs
endothelial.
Design.
We insert these signatures into the designer mRNA to target specific cells.
Hyperselective translation activates malignant cells to make cancer-fighting proteins. Other cells can be
activated to make health-promoting ones.
Deliver.
We control the designer mRNA’s journey into specific cells within target tissue using proprietary lipid
nanoparticles that evade default accumulation in the liver.
